Nicox Aktie
| 0,33EUR | 0,00EUR | -0,60% |
WKN DE: A143G8 / ISIN: FR0013018124
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 32 | 11 | 11 | 5 | 5 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,27 | 0,48 | 0,63 | 1,57 | 3,35 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 48 | 34 | 16 | 22 | 9 |
| Summe Anlagevermögen | 67 | 59 | 37 | 2 | 2 |
| Summe Aktiva | 115 | 93 | 53 | 24 | 10 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 39 | 41 | 32 | 21 | 4 |
| Summe Eigenkapital | 76 | 52 | 21 | 3 | 6 |
| Summe Passiva | 115 | 93 | 53 | 24 | 10 |
Adresse
| Emerald Square, 06410 Biot | |
| Telefon | +33 (4) 97-24-53-00 |
| Fax | +33 (4) 97-24-53-99 |
| Internet | http://www.nicox.com |
Management
|
Christine Placet
Director |
|
Damian Marron
Chairman |
|
Doug Hubatsch
Chief Scientific Officer |
|
Emmet Purtill
Vice President-Business Development |
|
Gavin M. Spencer
Chief Executive Officer & Director |
|
Marc Le Bozec
Independent Director |
|
Sandrine Gestin
Vice President-Finance |